One strategy to improve the activity of drugs is the conjugation of two bioactive 59 moieties. For instance, the conjugate of the iron chelator deferiprone and a 60 inhibitor epirubicin was evaluated using the isobolographic method as described 132 previously (Steverding and Wang, 2009 where GI 50(DFO,com) and GI 50(EPI,com) are the concentrations of deferoxamine and 146 epirubicin used in the combination to achieve 50% growth inhibition and GI 50(DFO,sin) 147 and GI 50(EPI,sin) are the concentrations of deferoxamine and epirubicin alone to achieve 148 the same effect. A CI value of <1, =1, and >1 indicates synergism, additive effect, and 149 antagonism, respectively. the GI 50 and MIC ratios of cytotoxic to trypanotoxic activities (selectivity indices) for 176 the thiosemicarbazones were much less favourable than those of anti-sleeping 177 sickness drugs. TSC24 and Dp44mT had a GI 50 ratio of <1 while their corresponding 178 MIC ratio was, at >100, more promising ( Table 2 ). The GI 50 and MIC ratios for 3-AP 179 were 2.85 and >1 indicating poor selectivity of this drug. In contrast, the GI 50 and 180 MIC ratios of anti-sleeping sickness drugs are much higher (pentamindine: 9,800 and 181 13,000; melarsoprol: 267 and >1,000; suramin: >100 and >1,000) ( (Table 1) . This finding supports the notion that both thiosemicarbazones 186 could chelate iron in cells, which may have contributed to the trypanotoxic activity of 187 the compounds. In contrast, addition of iron did not impair the anti-trypanosomalcells increased only 5-and 7-fold, respectively, which was lower than those observed 191 for the compounds for trypanosomes. As the addition of iron shifted the trypanotoxic 192 and the cytotoxic activity of the compounds in the same direction, no change in the 193 MIC and GI 50 ratios were observed apart from a 100-fold drop in the MIC ratios for 194 TSC24 and Dp44mT (Table 2) . To investigate whether the trypanotoxic action of TSC24 and Dp44mT was the 214 result from a synergistic effect of their iron chelating and topoisomerase II inhibiting 215 activity, a combination assay was carried out. Although the iron chelating properties 216 of TSC24 and Dp44mT is known to be due to their thiosemicarbazone scaffold, the 217 part of the molecules responsible for their topoisomerase inhibiting properties is notknown. Therefore, a combination assay was designed using two separate agents, the 219 iron chelator deferoxamine and the topoisomerase II inhibitor epirubicin. The 220 combination of deferoxamine with epirubicin showed an antagonistic effect with a CI 221 of 1.49±0.25 (Fig. 3) . Whereas the GI 50 of deferoxamine dropped from 10.8±2.1 μM 222 to 4.5±0.6 μM, the GI 50 of epirubicin remained unchanged (108±17 nM vs 113±14 223 nM). This result suggests that iron chelation and topoisomerase inhibition probably do 224 not show trypanocidal synergy. 225 
